Funds and ETFs Alpha Teknova, Inc.

Equities

TKNO

US02080L1026

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 13/05/2024 BST 5-day change 1st Jan Change
1.74 USD -3.33% Intraday chart for Alpha Teknova, Inc. -12.12% -53.35%

ETFs positioned on Alpha Teknova, Inc.

Name Weight AuM 1st Jan change Investor Rating
0.00% 17 M€ +4.15% -
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.8 USD
Average target price
5.5 USD
Spread / Average Target
+205.56%
Consensus
  1. Stock Market
  2. Equities
  3. TKNO Stock
  4. Funds and ETFs Alpha Teknova, Inc.